Annual Drug Patent Expirations for KYPROLIS
Kyprolis is a drug marketed by Onyx Therap and is included in one NDA. There are eleven patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for KYPROLIS.
This drug has one hundred and ninety-four patent family members in forty-one countries.
The generic ingredient in KYPROLIS is carfilzomib. Additional details are available on the carfilzomib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
